FACTS & FIGURES

BioNTech IMFS at a Glance

For the past two decades, BioNTech IMFS has been at the forefront of providing clinical supply for cell and gene therapy. Today, we are a leader in the development and manufacturing of cell and gene therapy products.

our background

our workplace

our gender

more than 160 passionate employees

infectious retroviral particles produced in 2016

0

product mix manufactured

2015

GMP batches share of total production

2015

EUFETS customers worldwide

image/svg+xml